Experimental group:Dengzhan Shengmai capsule

3 trials

Sponsors

Guangdong Provincial Hospital of Chinese Medicine (The Second Hospital affiliated to Guangzhou University of Chinese Medicine), XiYuan Hospital of China Academy of Chinese Medical Sciences

Conditions

Coronary heart disease complicated with heart failure with preserved ejection fractionminor ischemic stroke or transient ischemic attack

Phase 4

The pilot and feasibility trial on Dengzhan Shengmai capsules and Aspirin for Non-disabling Cerebrovascular Events (DANCE)

RecruitingChiCTR2000039184

Guangdong Provincial Hospital of Chinese Medicine (The Second Hospital affiliated to Guangzhou University of Chinese Medicine)minor ischemic stroke or transient ischemic attack

Start: 2020-10-20Updated: 2021-01-18

The pilot and feasibility trial on Dengzhan Shengmai capsules and Aspirin for Non-disabling Cerebrovascular Events (DANCE)

RecruitingITMCTR2000004027

Guangdong Provincial Hospital of Chinese Medicine (The Second Hospital affiliated to Guangzhou University of Chinese Medicine)minor ischemic stroke or transient ischemic attack

Start: 2020-10-20Updated: 2023-02-20

Evaluate the efficacy and safety of Dengzhan Shengmai Capsule in patients with Coronary heart disease complicated with heart failure with preserved ejection fraction:A multicenter, randomized, double-blind, placebo-controlled clinical trial

RecruitingChiCTR2300072852

XiYuan Hospital of China Academy of Chinese Medical SciencesCoronary heart disease complicated with heart failure with preserved ejection fraction

Start: 2023-06-27Updated: 2023-07-02